Optibrium introduces cloud-based version of StarDrop drug discovery platform

Optibrium announced that its drug discovery platform, StarDrop.

Ulixertinib by BioMed Valley Discoveries for Neurofibromatoses Type I (Von Recklinghausen’s Disease): Likelihood of Approval

Ulixertinib is under clinical development by BioMed Valley Discoveries and currently in Phase I for Neurofibromatoses Type I (Von Recklinghausen’s Disease).

June 20, 2024

Ipsen’s Onivyde regimen gains FDA approval for pancreatic cancer

Share this article Ipsen’s Onivyde regimen is indicated as a first-line treatment for metastatic pancreatic adenocarcinoma. Credit: MattL_Images / Shutterstock.com. The US Food and Drug

February 14, 2024

UTA biology professor awarded NIH grant for new super-resolution microscope

UTA will soon add a new piece of cutting-edge equipment to its already impressive and growing research armamentarium-;a type of super-resolution microscope (SRM) that allows

November 1, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.